These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 2213556)

  • 1. Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP3174: an active metabolite of DuP 753, an orally active antihypertensive agent.
    Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
    J Pharmacol Exp Ther; 1990 Oct; 255(1):211-7. PubMed ID: 2213556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
    Shibouta Y; Inada Y; Ojima M; Wada T; Noda M; Sanada T; Kubo K; Kohara Y; Naka T; Nishikawa K
    J Pharmacol Exp Ther; 1993 Jul; 266(1):114-20. PubMed ID: 8331552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different types of receptor interaction of peptide and nonpeptide angiotensin II antagonists revealed by receptor binding and functional studies.
    Wienen W; Mauz AB; Van Meel JC; Entzeroth M
    Mol Pharmacol; 1992 Jun; 41(6):1081-8. PubMed ID: 1614410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of DuP 532, a selective and noncompetitive AT1 receptor antagonist.
    Wong PC; Hart SD; Chiu AT; Herblin WF; Carini DJ; Smith RD; Wexler RR; Timmermans PB
    J Pharmacol Exp Ther; 1991 Nov; 259(2):861-70. PubMed ID: 1941632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonpeptide angiotensin II receptor antagonists. VIII. Characterization of functional antagonism displayed by DuP 753, an orally active antihypertensive agent.
    Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
    J Pharmacol Exp Ther; 1990 Feb; 252(2):719-25. PubMed ID: 2179531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonpeptide angiotensin II receptor antagonists. VII. Cellular and biochemical pharmacology of DuP 753, an orally active antihypertensive agent.
    Chiu AT; McCall DE; Price WA; Wong PC; Carini DJ; Duncia JV; Wexler RR; Yoo SE; Johnson AL; Timmermans PB
    J Pharmacol Exp Ther; 1990 Feb; 252(2):711-8. PubMed ID: 2313596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonpeptide angiotensin II receptor antagonists. IX. Antihypertensive activity in rats of DuP 753, an orally active antihypertensive agent.
    Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
    J Pharmacol Exp Ther; 1990 Feb; 252(2):726-32. PubMed ID: 2179532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.
    Siegl PK; Chang RS; Mantlo NB; Chakravarty PK; Ondeyka DL; Greenlee WJ; Patchett AA; Sweet CS; Lotti VJ
    J Pharmacol Exp Ther; 1992 Jul; 262(1):139-44. PubMed ID: 1625193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonpeptide angiotensin II receptor antagonists: insurmountable angiotensin II antagonism of EXP3892 is reversed by the surmountable antagonist DuP 753.
    Wong PC; Timmermans PB
    J Pharmacol Exp Ther; 1991 Jul; 258(1):49-57. PubMed ID: 2072311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype.
    Criscione L; de Gasparo M; Bühlmayer P; Whitebread S; Ramjoué HP; Wood J
    Br J Pharmacol; 1993 Oct; 110(2):761-71. PubMed ID: 8242249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174.
    Dickinson KE; Cohen RB; Skwish S; Delaney CL; Serafino RP; Poss MA; Gu Z; Ryono DE; Moreland S; Powell JR
    Br J Pharmacol; 1994 Sep; 113(1):179-89. PubMed ID: 7812609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II receptor antagonists. From discovery to antihypertensive drugs.
    Timmermans PB; Carini DJ; Chiu AT; Duncia JV; Price WA; Wells GJ; Wong PC; Wexler RR; Johnson AL
    Hypertension; 1991 Nov; 18(5 Suppl):III136-42. PubMed ID: 1937677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological properties of KT3-671, a novel nonpeptide angiotensin II receptor antagonist.
    Mochizuki S; Sato T; Furuta K; Hase K; Ohkura Y; Fukai C; Kosakai K; Wakabayashi S; Tomiyama A
    J Cardiovasc Pharmacol; 1995 Jan; 25(1):22-9. PubMed ID: 7723348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo pharmacology of DuP 753.
    Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
    Am J Hypertens; 1991 Apr; 4(4 Pt 2):288S-298S. PubMed ID: 1854454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of LR-B/081, a new highly potent, selective and orally active, nonpeptide angiotensin II AT1 receptor antagonist.
    Cirillo R; Renzetti AR; Cucchi P; Guelfi M; Salimbeni A; Caliari S; Castellucci A; Evangelista S; Subissi A; Giachetti A
    Br J Pharmacol; 1995 Mar; 114(6):1117-24. PubMed ID: 7620700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonpeptide angiotensin II receptor antagonist: pharmacokinetics and pharmacodynamics in rats of EXP3174, an active metabolite of losartan.
    Wong PC; Christ DD; Wong YN; Lam GN
    Pharmacology; 1996 Jan; 52(1):25-9. PubMed ID: 8966199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological and pharmacokinetic evaluation of EXP3312, an orally-active non-peptide angiotensin II-receptor antagonist.
    Wong YN; Wong PC
    J Pharm Pharmacol; 1996 May; 48(5):492-7. PubMed ID: 8799873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro pharmacology of L-158,809, a new highly potent and selective angiotensin II receptor antagonist.
    Chang RS; Siegl PK; Clineschmidt BV; Mantlo NB; Chakravarty PK; Greenlee WJ; Patchett AA; Lotti VJ
    J Pharmacol Exp Ther; 1992 Jul; 262(1):133-8. PubMed ID: 1625192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization of SR 47436, a new nonpeptide AT1 subtype angiotensin II receptor antagonist.
    Cazaubon C; Gougat J; Bousquet F; Guiraudou P; Gayraud R; Lacour C; Roccon A; Galindo G; Barthelemy G; Gautret B
    J Pharmacol Exp Ther; 1993 May; 265(2):826-34. PubMed ID: 8496828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro pharmacology of DuP 753.
    Chiu AT; McCall DE; Price WA; Wong PC; Carini DJ; Duncia JV; Wexler RR; Yoo SE; Johnson AL; Timmermans PB
    Am J Hypertens; 1991 Apr; 4(4 Pt 2):282S-287S. PubMed ID: 1854453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.